These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 17082717
1. Predictive factors for masked hypertension within a population of controlled hypertensives. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. J Hypertens; 2006 Dec; 24(12):2365-70. PubMed ID: 17082717 [Abstract] [Full Text] [Related]
2. [Is masked hypertension an artefact due to the blood pressure measurement method and threshold effects?]. Poncelet P, Clerson P, Ribstein J, Bassous M, Scart Gres C. Arch Mal Coeur Vaiss; 2005 Dec; 98(7-8):751-6. PubMed ID: 16220742 [Abstract] [Full Text] [Related]
3. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Ishikawa J, Kario K, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K, J-MORE Group. Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523 [Abstract] [Full Text] [Related]
4. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, Tanaka H, Yoshiike N. Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598 [Abstract] [Full Text] [Related]
5. [Prevalence and mechanism of masked hypertension: the ol'mesures survey]. Bobrie G, Clerson P, Cuchet A, Mahmoudi A, Postel-Vinay N, Chatellier G. Arch Mal Coeur Vaiss; 2006 Oct; 99(7-8):760-3. PubMed ID: 17061460 [Abstract] [Full Text] [Related]
6. Predictors of masked hypertension among treated hypertensive patients: an interesting association with orthostatic hypertension. Barochiner J, Cuffaro PE, Aparicio LS, Alfie J, Rada MA, Morales MS, Galarza CR, Waisman GD. Am J Hypertens; 2013 Jul; 26(7):872-8. PubMed ID: 23482377 [Abstract] [Full Text] [Related]
7. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function. Marchesi C, Maresca AM, Solbiati F, Franzetti I, Laurita E, Nicolini E, Gianni M, Guasti L, Marnini P, Venco A, Grandi AM. Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691 [Abstract] [Full Text] [Related]
8. Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Andalib A, Akhtari S, Rigal R, Curnew G, Leclerc JM, Vaillancourt M, Tardif JC. Intern Med J; 2012 Mar; 42(3):260-6. PubMed ID: 21118414 [Abstract] [Full Text] [Related]
9. Home blood pressure monitoring in paediatric chronic hypertension. Furusawa EA, Filho UD, Koch VH. J Hum Hypertens; 2009 Jul; 23(7):464-9. PubMed ID: 19279660 [Abstract] [Full Text] [Related]
10. Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study. Obara T, Ohkubo T, Asayama K, Kikuya M, Metoki H, Inoue R, Komai R, Murai K, Hashimoto J, Totsune K, Imai Y, J-Home Study Group. Clin Exp Hypertens; 2008 Apr; 30(3):277-87. PubMed ID: 18425707 [Abstract] [Full Text] [Related]
11. Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension? Yoon HJ, Ahn Y, Park JB, Park CG, Youn HJ, Choi DJ, Shin JH, Kim DW, Rim SJ, Bae JH, Korean Hypertension Research Network. Clin Exp Hypertens; 2010 Apr; 32(7):480-5. PubMed ID: 21029014 [Abstract] [Full Text] [Related]
12. The clinical significance of white-coat and masked hypertension. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G. Blood Press Monit; 2007 Dec; 12(6):387-9. PubMed ID: 18277317 [Abstract] [Full Text] [Related]
13. [Assessement of home blood pressure with a monitor including MAM technology: comparison with the standard monitor]. Dourmap-Collas C, Villeneuve F, Jaboureck O, Chantrel F, Hanon O, Girerd X, Club des jeunes hypertensiologues. Arch Mal Coeur Vaiss; 2006 Dec; 99(7-8):754-7. PubMed ID: 17061459 [Abstract] [Full Text] [Related]
15. Home blood pressure measurement may lead to less strict control of office blood pressure. Eto K, Tsuchihashi T, Ohta Y, Onaka U, Ueno M. Clin Exp Hypertens; 2008 Apr; 30(3):225-31. PubMed ID: 18425702 [Abstract] [Full Text] [Related]
16. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y. Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [Abstract] [Full Text] [Related]
17. Self-measurement of blood pressure in arterial hypertension--preliminary results from the AMPA study. Maldonado J, Pereira T, Estudo AMPA. Rev Port Cardiol; 2009 Jan; 28(1):7-21. PubMed ID: 19388489 [Abstract] [Full Text] [Related]
18. Determinants of masked hypertension in the general population: the Finn-Home study. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499 [Abstract] [Full Text] [Related]
19. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. Wang GL, Li Y, Staessen JA, Lu L, Wang JG. J Hypertens; 2007 Dec; 25(12):2398-405. PubMed ID: 17984660 [Abstract] [Full Text] [Related]
20. Prevalence and persistence of masked hypertension in treated hypertensive patients. Verberk WJ, Thien T, Kroon AA, Lenders JW, van Montfrans GA, Smit AJ, de Leeuw PW. Am J Hypertens; 2007 Dec; 20(12):1258-65. PubMed ID: 18047914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]